\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ lumbar\\ puncture\\ was\\ preformed\\.\ \(0\)\
\-\ two\\ new\\ lesions\\ are\\ seen\\ in\\ the\\ brain\\ in\\ opposite\\ hemispheres\\ that\\ are\\ oviod\\,\\ homogeneously\\ hyperdense\\ and\\ enhancing\\,\\ t1\\ dark\\ and\\ t2\\ bright\\ with\\ restricted\\ difussion\\.\\ \ \(0\)\
\-\ no\\ occular\\ abnormalities\\.\ \(0\)\
\-\ lymphoma\\,\\ cns\ \(0\)\
\-\ primary\\ brain\\ malignancy\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ lymphoma\ \(373\)\
\-\ abscess\ \(594\)\
\-\ sarcoid\ \(163\)\
\-\ ms\ \(3148\)\
\-\ pml\ \(0\)\
\-\ toxoplasmosis\ \(14\)\
\-\ known\\ diffuse\\ large\\ b\\-cell\\ lymphoma\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ oviod\\:\\ 0\\.15199169696493964\ \(0\)\
\-\ difussion\\:\\ 0\\.15199169696493964\ \(0\)\
\-\ occular\\:\\ 0\\.14004088350700952\ \(0\)\
\-\ lymphoma\\:\\ 0\\.1263206190201458\ \(0\)\
\-\ pml\\:\\ 0\\.1210992923230766\ \(0\)\
\-\ preformed\\:\\ 0\\.1091484788651465\ \(0\)\
\-\ opposite\\:\\ 0\\.0994999307972944\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.09453989506536714\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.0917070838362072\ \(0\)\
\-\ puncture\\:\\ 0\\.09069259245650145\ \(0\)\
\-\ brain\\:\\ 0\\.0886672939069918\ \(0\)\
\-\ homogeneously\\:\\ 0\\.08598063840478282\ \(0\)\
\-\ dark\\:\\ 0\\.08055833961336148\ \(0\)\
\-\ ms\\:\\ 0\\.07874177899857136\ \(0\)\
\-\ hemispheres\\:\\ 0\\.07849721632629625\ \(0\)\
\-\ sarcoid\\:\\ 0\\.07559830388143421\ \(0\)\
\-\ cns\\:\\ 0\\.07539426150821003\ \(0\)\
\-\ hyperdense\\:\\ 0\\.07365902830511198\ \(0\)\
\-\ bright\\:\\ 0\\.07365902830511198\ \(0\)\
\-\ restricted\\:\\ 0\\.06780545692034702\ \(0\)\
\-\ lumbar\\:\\ 0\\.0626506012702485\ \(0\)\
\-\ malignancy\\:\\ 0\\.056932580651750275\ \(0\)\
\-\ abnormalities\\:\\ 0\\.05411663140858994\ \(0\)\
\-\ new\\:\\ 0\\.05134117201380273\ \(0\)\
\-\ t1\\:\\ 0\\.04669819890041799\ \(0\)\
\-\ known\\:\\ 0\\.04662157042178999\ \(0\)\
\-\ abscess\\:\\ 0\\.04658338351955633\ \(0\)\
\-\ enhancing\\:\\ 0\\.046206095394564814\ \(0\)\
\-\ diffuse\\:\\ 0\\.044603576213367496\ \(0\)\
\-\ primary\\:\\ 0\\.04364455625682235\ \(0\)\
\-\ two\\:\\ 0\\.042195366165793204\ \(0\)\
\-\ t2\\:\\ 0\\.04169980635776469\ \(0\)\
\-\ are\\:\\ 0\\.04016806456998626\ \(0\)\
\-\ lesions\\:\\ 0\\.039440698385240475\ \(0\)\
\-\ metastatic\\:\\ 0\\.03708809316579466\ \(0\)\
\-\ large\\:\\ 0\\.03221624882467379\ \(0\)\
\-\ no\\:\\ 0\\.029670487955303516\ \(0\)\
\-\ seen\\:\\ 0\\.029114269225305002\ \(0\)\
\-\ that\\:\\ 0\\.025447943595841783\ \(0\)\
\-\ disease\\:\\ 0\\.024081681745098348\ \(0\)\
\-\ was\\:\\ 0\\.01703926762437391\ \(0\)\
\-\ in\\:\\ 0\\.014530938970353619\ \(0\)\
\-\ \\,\\:\\ 0\\.014002244768135554\ \(0\)\
\-\ and\\:\\ 0\\.006207207094214429\ \(0\)\
\-\ the\\:\\ 0\\.0023836083569590653\ \(0\)\
\-\ with\\:\\ 0\\.002017313380860168\ \(0\)\
\-\ \\.\\:\\ 0\\.0018361829015868763\ \(0\)\
